Table 2.
Baseline characteristics of all randomized participants.
| Total (n = 107) | Peanut (n = 57) | Control (n = 50) | |
|---|---|---|---|
| Age, years | 58 ± 14 | 59 ± 14 | 58 ± 15 |
| Female, n (%) | 70 (65) | 41 (72) | 29 (58) |
| Weight, kg | 92.2 ± 17.2 | 91.6 ± 17.6 | 92.9 ± 16.9 |
| BMI, kg/m2 | 33.1 ± 5.4 | 33.1 ± 4.9 | 33.0 ± 6.0 |
| Waist circumference, cm | 109 ± 12.9 | 108 ± 13.4 | 109 ± 12.5 |
| Systolic blood pressure, mmHg | 128 ± 16 | 126 ± 15 | 129 ± 17 |
| Diastolic blood pressure, mmHg | 81 ± 10 | 81 ± 10 | 81 ± 10 |
| AUSDRISK Score | 15.3 ± 4.7 | 15.0 ± 4.7 | 15.6 ± 4.7 |
| Fasting plasma glucose, mmol/L | 5.1 ± 0.7 | 5.1 ± 0.6 1 | 5.2 ± 0.8 2 |
| Fasting insulin, u/mL | 11.1 ± 6.7 | 10.6 ± 6.9 | 11.8 ± 6.3 2 |
| HbA1c, % | 5.6 ± 0.4 | 5.6 ± 0.3 | 5.6 ± 0.6 3 |
| 2-h glucose, mmol/L | 5.9 ± 2.3 | 5.7 ± 1.8 1 | 6.2 ± 2.9 2 |
| Prescribed antihypertensive medication, n (%) | 14 (13) | 5 (9) | 9 (18) |
Data presented as mean ± standard deviations, unless otherwise stated; 1 n = 56; 2 n = 44; 3 n = 45. AUSDRISK, Australian type 2 diabetes risk assessment tool; BMI, body mass index; HbA1c, hemoglobin A1c.